Axsome Therapeutics (AXSM) Current Assets (2022 - 2025)
Historic Current Assets for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to $565.3 million.
- Axsome Therapeutics' Current Assets rose 1799.76% to $565.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $565.3 million, marking a year-over-year increase of 1799.76%. This contributed to the annual value of $485.1 million for FY2024, which is 380.73% down from last year.
- According to the latest figures from Q3 2025, Axsome Therapeutics' Current Assets is $565.3 million, which was up 1799.76% from $536.6 million recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Current Assets ranged from a high of $565.3 million in Q3 2025 and a low of $86.8 million during Q1 2022
- In the last 4 years, Axsome Therapeutics' Current Assets had a median value of $479.1 million in 2024 and averaged $400.9 million.
- Per our database at Business Quant, Axsome Therapeutics' Current Assets skyrocketed by 39980.53% in 2023 and then crashed by 1090.25% in 2024.
- Quarter analysis of 4 years shows Axsome Therapeutics' Current Assets stood at $245.6 million in 2022, then skyrocketed by 105.28% to $504.3 million in 2023, then fell by 3.81% to $485.1 million in 2024, then rose by 16.55% to $565.3 million in 2025.
- Its Current Assets stands at $565.3 million for Q3 2025, versus $536.6 million for Q2 2025 and $494.6 million for Q1 2025.